FIELD: medicine.
SUBSTANCE: for treatment of patients with ischemic heart disease in addition to basic therapy introduced is cudesan in dose 25 drops simultaneously with preductal MB 35 mg 2 times per day during meal for 3 months, with further parenteral introduction of essentiale H in dose 0.5-1 g for 10 days, after that, enterally in dose 1 capsule 3 times per day for 20 days. Course of treatment is repeated 3 times per year.
EFFECT: expressed anti-ischemic effect and normalisation of processes of lipid peroxidation, including in patients with severe affection of coronary channel and expressed diastolic dysfunction of left ventricle.
2 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSING AND TREATING ENDOTHELIAL DYSFUNCTION IN METABOLIC DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE OF SECOND FUNCTIONAL CLASS | 2020 |
|
RU2737416C1 |
| METHOD OF CORONARY DISEASE TREATMENT | 2007 |
|
RU2349297C1 |
| THERAPY OF MITOCHONDRIAL INSUFFICIENCY IN UNDIFFERENTIATED FORMS OF CONNECTIVE TISSUE DYSPLASIA IN CHILDREN | 2006 |
|
RU2379038C2 |
| METHOD OF THERAPY OF CARDIOVASCULAR PATHOLOGY | 2011 |
|
RU2450272C1 |
| METHOD OF CORONARY DISEASE TREATMENT | 2006 |
|
RU2349296C2 |
| METHOD FOR TREATMENT OF HYPERLIPOIDEMIA, HYPERCOAGULATION, PEROXIDATION SYNDROMES | 2001 |
|
RU2195347C1 |
| METHOD FOR TREATING THE CASES OF CARDIAC ISCHEMIA DISEASE | 2004 |
|
RU2292924C2 |
| METHOD FOR DETERMINING THE RISK DEVELOPMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH PREMATURE ATRIAL CONTRACTION | 2017 |
|
RU2657189C1 |
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| METHOD OF ESTIMATING EFFICIENCY OF ISCHEMIC DISEASE TREATMENT | 1995 |
|
RU2122732C1 |
